Results 41 to 50 of about 3,189 (173)
Outcomes and salvage strategies for large B‐cell lymphoma progressing after second‐line CAR T‐cell therapy: A DESCAR‐T study from the LYSA group
HemaSphere, Volume 10, Issue 5, May 2026.Abstract
Relapse after chimeric antigen receptor (CAR) T‐cell therapy in large B‐cell lymphoma (LBCL) is associated with a dismal prognosis. Although Phase 3 trials have established CAR T‐cells as standard second‐line (2L) therapy, outcomes and optimal management after relapse in this setting remain unknown because no real‐world data are currently ...Pierre Sesques, Guillaume Manson, Guillaume Cartron, François‐Xavier Gros, Franck Morschhauser, Cristina Castilla‐Llorente, Gabriel Brisou, Pierre Bories, Catherine Thieblemont, Laurianne Drieu La Rochelle, Benoit Tessoulin, Axel André, Cedric Rossi, Jérôme Paillassa, Stephanie Guidez, Antoine Capes, Laura Herbreteau, Sylvain Choquet, Jacques‐Olivier Bay, Adrien Chauchet, Laure Lebras, Fabien Claves, Julie Abraham, Jean‐Valère Malfuson, Marie‐Thérèse Rubio, Justine Decroocq, Luc‐Matthieu Fornecker, Gandhi Damaj, Ludovic Fouillet, Magalie Joris, Michael Loschi, Olivier Hermine, Hadia Hafirassou, Emelie Van Zele, Vivien Dupont, Steven Le Gouill, Roch Houot, Vincent Camus +37 morewiley +1 more sourceMetastatic breast cancer: an updating
Biomedicine & Pharmacotherapy, 2006 This article reports on recent advances on metastatic breast cancer. Detection, prognostic factors, predictors of response to therapy and therapy, with particular regard to targeted therapies, were examined.Unlike current guidelines that yet do not routinely recommend intensive clinical-instrumental post-operative follow-up of breast cancer patients ...NICOLINI, ANTONIO, GIARDINO, ROBERTO, Carpi A., Ferrari P., Anselmi L., Colosimo S., Conte M., Fini M., Giavaresi G., Berti P., Miccoli P. +10 moreopenaire +3 more sourcesPaediatric‐onset autoimmune cytopenia: How can we reduce the long‐term mortality?
British Journal of Haematology, EarlyView.Nathalie Aladjidi, Thierry Leblanc, Helder Fernandes, Capucine Picard, Jacinta Bustamante, Frédéric Rieux‐Laucat, Mathieu Fusaro, Maud Tusseau, Charlotte Durand‐Teyssier, Emma Cohendy, Jérôme Granel, Stéphane Ducassou, Agathe Escudier, Despina Moshous, Marc Michel, Bertrand Godeau, Sébastien Héritier, Mony Fahd, Brigitte Bader‐Meunier, Alain Fischer, Guy Leverger, All collaborators from the French Paediatric Haemato‐Immunologic CEREVANCE Network +21 morewiley +1 more sourceSurgical Management of Zollinger‐Ellison Syndrome in Multiple Endocrine Neoplasia Type 1 an AFCE and GTE Cohort Study. (Association Francophone de Chirurgie Endocrinienne and Groupe d'étude des Tumeurs Endocrines)
World Journal of Surgery, Volume 50, Issue 5, Page 1300-1311, May 2026.To describe surgical indications, procedures and outcomes in patients operated for Zollinger‐Ellison syndrome (ZES) in multiple endocrine neoplasia type 1 (MEN1) using a large nationwide cohort. ABSTRACT Objective
To describe surgical indications, procedures and outcomes in patients operated for Zollinger‐Ellison syndrome (ZES) in multiple endocrine ...Sébastien Gaujoux, François Pattou, Guillaume Cadiot, Mustapha Adham, Philippe Bachellier, Jean‐Pierre Bail, Robert Caiazzo, Nicolas Carrere, Philippe Chaffanjon, Sophie Deguelte, Gianluca Donatini, Bertrand Dousset, Matthieu Faron, Caroline Gronnier, Bruno Heyd, Jean‐Christophe Lifante, Jean Lubrano, Nicolas Meurisse, Eric Mirallié, Nicolas Santucci, Alain Sauvanet, Frédéric Sebag, Laurent Sulpice, Baudoin Thebault, Jean‐Jacques Tuech, Thomas Walter, Christine Binquet, Pierre Goudet +27 morewiley +1 more sourceIntegration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults
HemaSphere, Volume 10, Issue 4, April 2026.Abstract
This study aimed to define the potential role of circulating tumor DNA (ctDNA) in children, adolescents, and young adults (CAYA) with classical Hodgkin lymphoma (cHL). This prospective trial was conducted in France between 2019 and 2023 and recruited CAYA patients (≤25 years old) with a new diagnosis of cHL.Mathieu Simonin, Mathieu Viennot, Stéphanie Haouy, Stéphane Ducassou, Catherine Curtillet, Nathalie Garnier, Aurélie Phulpin, Catherine Paillard, Charlotte Rigaud, Marie‐Laure Couec, Liana Carausu, Jacinthe Bonneau, Isabelle Pellier, Melissa Barbati, Frédéric Millot, Marie‐Émilie Dourthe, Justina Kanold, Pascale Schneider, Jean‐Louis Stephan, Camille Leglise, Claire Pluchart, Pierre‐Julien Viailly, Victor Michel, Sabah Boudjemaa, Bénédicte Jonca, Thierry Leblanc, Judith Landman‐Parker, Fabrice Jardin +27 morewiley +1 more sourceHLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker
Frontiers in ImmunologySince the advent of anti-PD1 immune checkpoint inhibitor (ICI) immunotherapy, cutaneous melanoma has undergone a true revolution with prolonged survival, as available 5-year updates for progression-free survival and overall survival demonstrate a durable Karim Amrane, Karim Amrane, Coline Le Meur, Benjamin Besse, Benjamin Besse, Patrice Hemon, Pierre Le Noac’h, Pierre Le Noac’h, Olivier Pradier, Christian Berthou, Christian Berthou, Ronan Abgral, Ronan Abgral, Arnaud Uguen, Arnaud Uguen +14 moredoaj +1 more sourceA nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events
Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1179-1190, February 2026.Abstract Aims
A nationwide observational study was conducted to assess the 12‐month effectiveness of AID systems in the routine care of people with Type 1 diabetes (PwT1D). Methods
All PwT1D, adults, and children, who initiated AID between January 1, 2022, and December 31, 2022, were included across 79 centres.Jean‐Pierre Riveline, Jean‐Baptiste Julla, Elisabeth Bonnemaison, Michael Joubert, Sandrine Lablanche, Agnès Sola Gazagnes, Delphine Demarsy, Didier Gouet, Pauline Schaepelynck, Chloé Amouyal, Fabienne Dalla Vale, Anne Schletzer‐Mari, Sylvaine Clavel, Anne Spiteri, Catherine Campinos, Sandrine Favre, Igor Tauveron, Laurence Mathivon, Sophie Borot, Guy Fagherazzi, Marc D. Breton, Jean‐François Gautier, Eric Renard, for the OB2F study group, Jean‐Pierre Riveline, Manal Al Masri‐Shbat, Emmanuel Cosson, Isabela Banu, Michael Joubert, Agnès Sola Gazagnes, Gaetan Prevost, Sandrine Lablanche, Pauline Schaepelynck, Charles Thivolet, Nicolas Chevalier, Sophie Borot, Bruno Guerci, Elise Bismuth, Jacques Beltrand, Delphine Demarsy, Emmanuelle Bourrinet, Didier Gouet, Lucien Marchand, Louis Gerbaud‐Morlaes, Salha Fendri, Sylvaine Clavel, René Valero, Emmanuel Sonnet, Blandine Delenne, Jean‐Paul Donnet, Emma Carreira, Cedric Fagour, Camille Vatier, Rosine Guintrand, Luc Rakotoarisoa, Aurélie Carlier, Anne Spiteri, Igor Tauveron, Lemoine Amal, Letitia Pantalone, Anne Schletzer, Karen Berthelon, Natacha Germain, Françoise Latil Plat, Aroua Temessek, Marie Mansilla, Lorraine Thomesse, Fabienne Dalla Valle, Anne‐Cécile Paepegaey, Nadège Bachere, Candace Ben Signor, Samy Hadjadj, Thanh Lan Dangduy, Mathieu Giraud, Sandrine Favre, Joëlle Dupont, Anna Flaus Furmaniuk, Laure Houdon Nguyen, Patricia Pigeon Kherkiche, Anne‐Cécile Gauthier, Anne Vambergue, Alina Radu, Sandra Pochelu, Abine Baron, Chloé Amouyal, Jennifer Allain‐Cohen, Mariana Geamanu, Florent Verdier, Yannis Chartier, Nathalie Garrec, Annie Sfez, laurence Mathivon, Christine Rouby, Emeline Renard, Agnès Tamboura, Leïla Mchirgui, PH Emilie Georget, Elise Pinto da Rocha, Laure Oilleau‐Barral +98 morewiley +1 more source
